| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.975 | 0.001 | 0.975 | 5 Hydroxytryptamine 3B antagonist | 0.595 0.002 CID_85629606 | ||
| 0.915 | 0.003 | 0.915 | 5 Hydroxytryptamine antagonist | 0.642 0.005 CID_85629606 | ||
| 0.911 | 0.002 | 0.911 | Alpha 2b adrenoreceptor antagonist | 0.55 0.004 CID_85629606 | ||
| 0.898 | 0.001 | 0.898 | 5 Hydroxytryptamine 5A antagonist | 0.512 0.003 CID_85629606 | ||
| 0.892 | 0.002 | 0.892 | 5 Hydroxytryptamine 5 antagonist | 0.435 0.003 CID_85629606 | ||
| 0.852 | 0.003 | 0.852 | 5 Hydroxytryptamine 2B antagonist | 0.515 0.005 CID_85629606 | ||
| 0.83 | 0.003 | 0.83 | Alpha 2 adrenoreceptor antagonist | 0.58 0.004 CID_85629606 | ||
| 0.829 | 0.003 | 0.829 | Dopamine antagonist | 0.541 0.005 CID_85629606 | ||
| 0.821 | 0.003 | 0.821 | 5 Hydroxytryptamine 2 antagonist | 0.541 0.005 CID_85629606 | ||
| 0.797 | 0.003 | 0.797 | Dopamine D2 antagonist | 0.511 0.005 CID_85629606 | ||
| 0.787 | 0 | 0.787 | Prolactin inhibitor | 0.632 0.001 CID_85629606 | ||
| 0.784 | 0.003 | 0.784 | Dopamine agonist | 0.655 0.004 CID_85629606 | ||
| 0.779 | 0.003 | 0.779 | 5 Hydroxytryptamine 2A antagonist | 0.506 0.005 CID_85629606 | ||
| 0.77 | 0.003 | 0.77 | 5 Hydroxytryptamine 2C antagonist | 0.343 0.007 CID_85629606 | ||
| 0.757 | 0.003 | 0.757 | Alpha 2a adrenoreceptor antagonist | 0.341 0.005 CID_85629606 | ||
| 0.742 | 0.003 | 0.742 | 5 Hydroxytryptamine 7 antagonist | 0.56 0.004 CID_85629606 | ||
| 0.735 | 0.003 | 0.735 | Alpha 2c adrenoreceptor antagonist | 0.366 0.005 CID_85629606 | ||
| 0.713 | 0.003 | 0.713 | Dopamine D2 agonist | 0.535 0.004 CID_85629606 | ||
| 0.711 | 0.003 | 0.711 | 5 Hydroxytryptamine 1F antagonist | 0.607 0.004 CID_85629606 | ||
| 0.701 | 0.002 | 0.701 | Dopamine D1 antagonist | 0.458 0.004 CID_85629606 | ||
| 0.691 | 0.001 | 0.691 | Prolactin release inhibitor | 0.499 0.001 CID_85629606 | ||
| 0.671 | 0.002 | 0.671 | 5 Hydroxytryptamine 1D antagonist | 0.328 0.004 CID_85629606 | ||
| 0.669 | 0.002 | 0.669 | 5 Hydroxytryptamine 3 antagonist | 0.308 0.004 CID_85629606 | ||
| 0.651 | 0.003 | 0.651 | Alpha 1 adrenoreceptor agonist | 0.239 0.005 CID_85629606 | ||
| 0.643 | 0.011 | 0.643 | 5 Hydroxytryptamine release stimulant | 0.58 0.017 CID_85629606 | ||
| 0.634 | 0.003 | 0.634 | 5 Hydroxytryptamine 1B antagonist | 0.294 0.005 CID_85629606 | ||
| 0.633 | 0.004 | 0.633 | Alpha adrenoreceptor antagonist | 0.388 0.01 CID_85629606 | ||
| 0.62 | 0.003 | 0.62 | Dopamine D3 antagonist | 0.392 0.004 CID_85629606 | ||
| 0.577 | 0.012 | 0.611 | Nootropic | 0.611 0.01 CID_85629606 | CID_85629606 | |
| 0.546 | 0.003 | 0.546 | Alpha 1d adrenoreceptor antagonist | 0.187 0.01 CID_85629606 | ||
| 0.57 | 0.033 | 0.57 | Analgesic | 0.514 0.045 CID_85629606 | ||
| 0.541 | 0.003 | 0.541 | Alpha adrenoreceptor agonist | 0.203 0.008 CID_85629606 | ||
| 0.478 | 0.005 | 0.478 | 5 Hydroxytryptamine 1 antagonist | 0.19 0.018 CID_85629606 | ||
| 0.474 | 0.005 | 0.474 | Alpha 1 adrenoreceptor antagonist | 0.171 0.025 CID_85629606 | ||
| 0.46 | 0.005 | 0.46 | Alpha 1a adrenoreceptor antagonist | 0.14 0.025 CID_85629606 | ||
| 0.493 | 0.039 | 0.493 | Antiobesity | 0.404 0.064 CID_85629606 | ||
| 0.454 | 0.004 | 0.454 | Alpha 1b adrenoreceptor antagonist | 0.147 0.023 CID_85629606 | ||
| 0.401 | 0.002 | 0.401 | 5 Hydroxytryptamine 4 antagonist | 0.172 0.003 CID_85629606 | ||
| 0.404 | 0.005 | 0.404 | 5 Hydroxytryptamine 1A antagonist | 0.134 0.023 CID_85629606 | ||
| 0.396 | 0.002 | 0.396 | 5 Hydroxytryptamine 6 antagonist | 0.193 0.004 CID_85629606 | ||
| 0.394 | 0.003 | 0.394 | Alpha 2 adrenoreceptor agonist | 0.153 0.006 CID_85629606 | ||
| 0.26 | 0.009 | 0.26 | Dopamine D4 antagonist | 0.119 0.022 CID_85629606 | ||
| 0.267 | 0.016 | 0.267 | Antiadrenergic | 0.191 0.026 CID_85629606 | ||
| 0.261 | 0.016 | 0.261 | Adrenaline antagonist | 0.185 0.026 CID_85629606 | ||
| 0.276 | 0.043 | 0.276 | Sigma receptor agonist | 0.276 0.043 CID_85629606 | ||
| 0.22 | 0.013 | 0.22 | 5 Hydroxytryptamine agonist | 0.162 0.019 CID_85629606 | ||
| 0.182 | 0.005 | 0.182 | Neuropeptide Y5 antagonist | 0.172 0.006 CID_85629606 | ||
| 0.171 | 0.005 | 0.171 | Dopamine D5 antagonist | 0.166 0.005 CID_85629606 | ||
| 0.247 | 0.109 | 0.247 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.246 0.11 CID_85629606 | ||
| 0.168 | 0.037 | 0.168 | MAP3K9 inhibitor | 0.124 0.106 CID_85629606 | ||
| 0.13 | 0.007 | 0.13 | 5 Hydroxytryptamine 3A antagonist | 0.122 0.009 CID_85629606 | ||
| 0.128 | 0.018 | 0.128 | Alpha 2d adrenoreceptor antagonist | 0.128 0.018 CID_85629606 | ||
| 0.124 | 0.019 | 0.131 | Histamine H2 receptor antagonist | 0.131 0.015 CID_85629606 | CID_85629606 | |
| 0.12 | 0.024 | 0.125 | Opioid kappa receptor antagonist | 0.125 0.022 CID_85629606 | CID_85629606 | |
| 0.128 | 0.033 | 0.128 | Opioid antagonist | 0.125 0.034 CID_85629606 | ||
| 0.099 | 0.017 | 0.102 | Protein kinase C eta inhibitor | 0.102 0.016 CID_85629606 | CID_85629606 | |
| 0.108 | 0.036 | 0.122 | Neuropeptide Y antagonist | 0.122 0.029 CID_85629606 | CID_85629606 | |
| 0.073 | 0.004 | 0.073 | Dopamine D1 agonist | 0.049 0.005 CID_85629606 | ||
| 0.078 | 0.014 | 0.078 | Nicotinic receptor alpha4 subunit antagonist | 0.076 0.014 CID_85629606 | ||
| 0.067 | 0.005 | 0.067 | Glucose-6-phosphate dehydrogenase inhibitor | 0.065 0.006 CID_85629606 | ||
| 0.094 | 0.034 | 0.094 | Analgesic, opioid | 0.08 0.047 CID_85629606 | ||
| 0.094 | 0.034 | 0.094 | Opioid mu receptor antagonist | 0.093 0.034 CID_85629606 | ||
| 0.083 | 0.024 | 0.083 | Potassium channel Kv1.5 blocker | |||
| 0.079 | 0.02 | 0.125 | Bromodomain-containing protein 4 inhibitor | 0.125 0.009 CID_85629606 | CID_85629606 | |
| 0.107 | 0.05 | 0.199 | Antihistaminic | 0.199 0.021 CID_85629606 | CID_85629606 | |
| 0.059 | 0.004 | 0.059 | 5 Hydroxytryptamine 6 agonist | 0.052 0.004 CID_85629606 | ||
| 0.099 | 0.048 | 0.193 | Histamine antagonist | 0.193 0.02 CID_85629606 | CID_85629606 | |
| 0.07 | 0.019 | 0.07 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.066 0.02 CID_85629606 | ||
| 0.065 | 0.015 | 0.11 | Secretase gamma inhibitor | 0.11 0.005 CID_85629606 | CID_85629606 | |
| 0.073 | 0.027 | 0.079 | 5 Hydroxytryptamine 1 agonist | 0.079 0.025 CID_85629606 | CID_85629606 | |
| 0.052 | 0.008 | 0.052 | AMPA receptor agonist | 0.052 0.008 CID_85629606 | ||
| 0.118 | 0.076 | 0.272 | Nav1.3 sodium channel blocker | 0.272 0.011 CID_85629606 | CID_85629606 | |
| 0.061 | 0.025 | 0.063 | 5 Hydroxytryptamine 1B agonist | 0.063 0.024 CID_85629606 | CID_85629606 | |
| 0.046 | 0.012 | 0.076 | 5 Hydroxytryptamine 1D agonist | 0.076 0.005 CID_85629606 | CID_85629606 | |
| 0.085 | 0.051 | 0.085 | Adrenaline agonist | |||
| 0.054 | 0.027 | 0.054 | 5 Hydroxytryptamine 1A agonist | 0.042 0.035 CID_85629606 | ||
| 0.121 | 0.095 | 0.134 | Nav1.6 sodium channel blocker | 0.134 0.075 CID_85629606 | CID_85629606 | |
| 0.059 | 0.034 | 0.059 | Bombesin 3 receptor antagonist | |||
| 0.037 | 0.014 | 0.041 | Protein kinase C beta II inhibitor | 0.041 0.01 CID_85629606 | CID_85629606 | |
| 0.068 | 0.046 | 0.069 | Protein kinase C alpha inhibitor | 0.069 0.045 CID_85629606 | CID_85629606 | |
| 0.075 | 0.061 | 0.075 | Acetylcholine nicotinic antagonist | 0.073 0.064 CID_85629606 | ||
| 0.034 | 0.021 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.019 CID_85629606 | CID_85629606 | |
| 0.139 | 0.126 | 0.14 | Psychostimulant | 0.14 0.125 CID_85629606 | CID_85629606 | |
| 0.036 | 0.024 | 0.038 | p53 inhibitor | 0.038 0.022 CID_85629606 | CID_85629606 | |
| 0.037 | 0.026 | 0.037 | Nicotinic receptor beta4 subunit antagonist | 0.037 0.026 CID_85629606 | ||
| 0.172 | 0.163 | 0.172 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.04 | 0.034 | 0.04 | Opioid kappa receptor agonist | |||
| 0.053 | 0.049 | 0.053 | Cannabinoid CB1 receptor agonist | |||
| 0.046 | 0.043 | 0.046 | 5 Hydroxytryptamine 2 agonist | |||
| 0.163 | 0.16 | 0.163 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.049 | 0.047 | 0.049 | Nicotinic receptor alpha7 subunit antagonist | 0.049 0.047 CID_85629606 | ||
| 0.046 | 0.044 | 0.046 | Opioid agonist | |||
| 0.069 | 0.07 | 0.076 | Histamine H1 receptor antagonist | 0.076 0.062 CID_85629606 | CID_85629606 | |
| 0.111 | 0.121 | 0.139 | Cholinergic | 0.139 0.087 CID_85629606 | CID_85629606 | |
| 0.085 | 0.132 | 0.107 | Acetylcholinesterase inhibitor | 0.107 0.094 CID_85629606 | CID_85629606 | |
| 0.112 | 0.182 | 0.29 | Anticonvulsant | 0.29 0.043 CID_85629606 | CID_85629606 | |
| 0.131 | 0.201 | 0.249 | Cardiotonic | 0.249 0.083 CID_85629606 | CID_85629606 | |
| 0.13 | 0.3 | 0.384 | 15-Lipoxygenase inhibitor | 0.384 0.081 CID_85629606 | CID_85629606 | |
| 0.03 | 0.358 | 0.121 | Sodium channel blocker | 0.121 0.083 CID_85629606 | CID_85629606 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |